Schwemmlein
Christoph Schwemmlein, Borken DE
Patent application number | Description | Published |
---|---|---|
20130160890 | DEVICE TO FORM A LENO SELVEDGE - A device for the formation of a leno selvedge includes a frame for installation on the heddle shafts of a loom. The frame has at least one needle pair for two leno threads. The needle pair is mounted in the frame so that it can pivot around the longitudinal axis of the frame, and the device includes a pivot drive for pivoting the needle pair. | 06-27-2013 |
20130333794 | DEVICE FOR MANUFACTURING A FABRIC, AND FABRIC - The subject of the invention is a device for manufacturing a fabric comprising a plurality of automatically working apparatus arranged next to one another on at least one carrier for manufacturing a leno weave (a leno weave apparatus), wherein two leno threads are fed to each leno weave apparatus; wherein the device for manufacturing the fabric has at least one weft thread picking device; wherein the weft thread is introduced into the shed of leno threads raised by a plurality of leno weave apparatus; wherein the weft thread is bound using at least two leno threads at a plurality of points behind the weft thread over the width of the fabric; wherein at least one of the leno weave apparatus arranged in the end region of the fabric carries out a higher number of interlacings for achieving a homogenized warp tension distribution over the width of the fabric than at least one leno weave apparatus arranged in the central region of the fabric; and/or wherein the lowering of the shed is carried out by the leno weave apparatus over the width of the fabric at different times for achieving a homogenized warp tension distribution. | 12-19-2013 |
Michael Schwemmlein, Rengensburg DE
Patent application number | Description | Published |
---|---|---|
20090297521 | CD33-SPECIFIC SINGLE-CHAIN IMMUNOTOXIN AND METHODS OF USE - A single-chain immunotoxin composition and method of treatment with the composition is disclosed. Preferably, the immunotoxin is comprised of a CD33-specific single chain Fv antibody fragment and a genetically engineered variant of | 12-03-2009 |
Michael Schwemmlein, Erlangen DE
Patent application number | Description | Published |
---|---|---|
20080267977 | Combined immunological agent and sensitizing agent for the treatment of cancer - A method and kit for inhibiting the proliferation of cancer cells are disclosed, based on a combination of an apoptosis-inducing immunologic agent, and a sensitizing agent. When used in cancer therapy, the two agents in combination enhance the anti-cancer treatment efficacy obtained with the immunologic agent or the sensitizing agent alone, by a supraadditive amount. | 10-30-2008 |
20090220501 | Anti-CD19 Antibody, Immunotoxin and Treatment Method - Provided is an immunotoxin including (a) an anti-CD19 antibody lacking an Fc fragment, (b) a modified exotoxin A protein having both Domains II and III, but lacking Domain I, and (c) a peptide linker joining the C-terminal end of the antibody to the N-terminal end of the modified exotoxin A protein. The linker is substantially resistant to extracellular cleavage. The modified exotoxin A protein may be further modified to include a C-terminal KDEL sequence (SEQ ID NO: 6) that promotes transport of the protein to the endoplasmic reticulum of cells that have taken up the immunotoxin. Also provided is an anti-CD19 antibody having enhanced binding activity, antibody-dependent cellular cytotoxicity (ADCC) and methods for using the antibody to treat a disease state associated with B-lineage cells that express CD19. The antibody variable light and variable heavy chains have unique sequences in their J region relative to known anti-CD19 antibody sequences. | 09-03-2009 |